1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDecember 1, 2026 deadline confirmed on page for the Winter 2026 cycle.
RFA: ACS-ASTRO Clinical Scientist Development Grant (CSDG) is sponsored by American Cancer Society. Provides funding for full-time faculty with clinical responsibilities to become independent clinician scientists.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
ASTRO-ACS Clinician Scientist Development Grant | American Cancer Society 2X GIFT MATCH: Your gift will be doubled. Donate Now. https://searchapi.
cancer. org Use double-quotes ("") around a phrase for an exact result Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT Call us at 1-800-227-2345 Available any time of day or night Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer.
Some of the topics we can assist with include: Referrals to patient-related programs or resources Donations, website, or event-related assistance For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science (EDS) Apply for a Research Grant Arizona (AZ) Discovery Boost Grants (DBG) ASTRO-ACS Clinician Scientist Development Grant (CSDG) Clinician Scientist Development Grant (CSDG) Discovery Boost Grants (DBG) HEALED Gold Medal RFA To Support Mind-Body-Spirit Wellness in Cancer Survivors Institutional Research Grants Mission Boost Grants (MBG) RFA: Extramural Discovery Science Accelerator Award RFA: Leukemia Exploration and Prevention Grant Program (LEAP) TheoryLab Collaborative (TLC) Grant RFA: Cancer Health Research Centers (CHERCs) RFA: Biology to Prevention Award (CRUK) RFA: ACS - Fanconi Cancer Foundation Discovery Boost Grant RFA: American Cancer Society Catalyst Awards RFA: American Cancer Society - Flatiron Real-World Data Impact Award RFA: Yosemite-American Cancer Society Award Extramural Grants Department Staff Contacts Definition of Research Areas FAQs: ACS Extramural Discovery Science and Grant Application Submissions Extramural Priority Research Areas Summer 2026 Grant Cycle: Summary of Changes American Cancer Society Research Events EDS: Our Research Programs Career Growth and Research Excellence Program Cancer Detection and Experimental Therapeutics (PF-CDET) Institutional Research Grants (IRG) Cell Biology and Immunology (PF-CBI) Clinical and Population Sciences (PF-CPS) Molecular Biology and Biochemistry (PF-MBB) Biochemistry and Immunology of Cancer Program DNA Mechanisms in Cancer (DMC) PRC Immunology and Blood Cell Development (IBCD) PRC RNA Mechanisms in Cancer (RMC) PRC Tumor Biochemistry and Endocrinology (TBE) PRC Mission Boost Grants (MBG) PRC Cell Biology and Preclinical Cancer Research Program Cancer Cell Biology (CCB) PRC Cancer Detection and Progression (CDP) PRC Experimental Therapeutics (ET) PRC Metastasis and Microenvironment (MM) PRC Clinical and Population Sciences Program Cancer Prevention and Health Promotion (CPHP) PRC Treatment, Palliative Care, and Survivorship Research (CTPS) Etiology, Screening, and Early Detection (ESED) Healthcare Outcomes, Policy, and Systems Research (HOPS) Peer Review Committees (PRCs) Discovery Scientific Council Community Research Partner Participation American Cancer Society Professors Nobel Laureates and the American Cancer Society American Cancer Society-Jiler Professors & Fellows Conference ASTRO-ACS Clinician Scientist Development Grant (CSDG) The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) have partnered to co-fund one Clinician Scientist Development Grant (CSDG).
The goal of the ASTRO-ACS CSDG is to foster the research career of a clinician scientist in radiation oncology. The investigator selected for funding will be required to become a member of ASTRO prior to grant activation. The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists.
This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. Specifically, for this RFA in partnership with ASTRO, the applicant must be in the radiation oncology field. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are especially encouraged to apply.
Typically, you ARE eligible to submit a proposal if you: Are a full-time faculty member at a US academic institution or eligible non-profit Have a doctoral degree (or terminal degree for their field), an active clinical license, and participate in clinical care. Applicants may also be board-certified clinical medical physicists.
Are not a current or former principal investigator (PI) of an individual mentored training grant Have not been the PI of an independent extramural research grant that is more than 1 year AND more than $100k direct costs, including multi-PI awards. We encourage applicants to review the grant policies document for additional, detailed information on eligibility requirements for all applicants and institutions.
Awards may be for 3 to 5 years with $135,000 a year for direct costs, plus 8% allowable indirect costs. Starting January 2024, all ASTRO-CSDG applications (new and resubmissions) must be submitted through the Clinician Scientist Development Grant application in proposalCentral. Applicants will select the ASTRO-CSDG RFA on the cover page of their application.
Applications will be accepted to the Winter 2026 application deadline, December 1, 2026. All Grant Policies All Grant Instructions Go to ProposalCentral and select Clinician Scientist Development Grant for the Application Help us end cancer as we know it, for everyone.
According to the current listing, eligibility includes: Full-time faculty at US academic institutions or eligible nonprofits with a doctoral degree, active clinical licensure, and participation in radiation oncology clinical care; no prior PI experience on grants exceeding b…. Confirm the full requirements in the official notice before applying.
The current listing shows $135,000 per year in direct costs plus 8% allowable indirect costs, for 3 to 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for RFA: ACS-ASTRO Clinical Scientist Development Grant (CSDG) are due December 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
RFA: ACS-ASTRO Clinical Scientist Development Grant (CSDG) is funded by American Cancer Society. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article